BLBoaz Levy

Boaz Levy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Boaz Levy has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Emily Manove

    Psychology Department University of Massachusetts Boston, MA, USA

    3 shared publications
  • Elena Tsoy

    Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, USA

    2 shared publications
  • Roger D. Weiss

    Department of Psychiatry Harvard Medical School/McLean Hospital Belmont, MA, USA

    2 shared publications
  • Tinatin Surguladze

    Department of Counseling and School Psychology, University of Massachusetts, Boston, MA, United States

    2 shared publications
  • Allison Elber

    From the Department of Counseling and School Psychology, University of Massachusetts, Boston, MA (CH, BL, JH, SG, AE, KF); Cleveland Clinic, Lerner College of Medicine, Ohio (AH); Tufts University School of Medicine, Boston, MA (DD); and McLean Hospital, Belmont, MA, Harvard Medical School (BL)

    1 shared publication
  • Anna Marie Medina

    Department of Psychology, Gonzaga University, Spokane, Washington, USA

    1 shared publication

Latest Publications

  • Open Access

    Subjective Versus Objective Assessment of Cognitive Functioning in Primary Care

    by Courtney Hess, Boaz Levy, Ardeshir Z. Hashmi, Jacqueline Hogan, Sarah Greenspan, Allison Elber, Kathryn Falcon, Daniel F. Driscoll

    Purpose: This study examined the clinical utility of highly efficient subjective and objective screens of cognitive impairment. Method: Participants (N = 124, age ≥ 65, mean = 73.59, SD = 6.26) completed a 2-item questionnaire of subjective memory functioning, a brief computerized cognitive test, and the Montreal Cognitive Assessment (MoCA). Next, participants were assigned to 1 of 4 conditions, based on their subjective (low/high) and objective (impaired/unimpaired) levels of cognitive functioning. Further analysis divided the sample into age-based groups (ie, age < 75, age ≥ 75). Results: The proportion of participants in the impaired subsample (ie, MoCA < 26), who reported a high level of subjective concern about their memory, was low (ie, 0.15). Among unimpaired participants, analysis detected significant group differences across subjective memory levels (P < .0003) and age (P < .005) categories on one of the three tasks of the computerized test (ie, cognitive control). In contrast, the MoCA offered no differentiation between these groups. Conclusion: Screening protocols in which cognitive testing is administered subsequent to patient complaint are prone to underdiagnosis. In addition, common dementia screens are insensitive to subjective deficits and healthy cognitive aging. Therefore, they may lead to dismissing valid concerns that deserve preventive attention. Primary care needs efficient screening tools that are sensitive to prodromal decline.


  • Developing Cognitive Markers of Alzheimer’s Disease for Primary Care: Implications for Behavioral and Global Prevention

    by Boaz Levy, Elena Tsoy, Samuel Gable

    A comprehensive approach to the prevention of Alzheimer’s disease (AD) warrants a synergy across multiple domains and procedures. Whereas the study of biological markers has mobilized major activity in the field, the development of cognitive markers is largely ignored, despite the unique advantages they may offer. Cognitive markers essentially assess the core clinical feature that biological markers intend to predict. In this respect, cognitive markers expand the foundation of preclinical diagnostics and disease staging in a manner that integrates both physiological and psychological factors. In addition, the cost-effective implementation of cognitive markers makes them remarkably conducive to community-wide screenings, and thereby a vital component of any global blueprint for prevention. Specifically, in the primary care setting, cognitive markers may provide effective gate keeping for more invasive, labor intensive, and expensive procedures. From this perspective, cognitive markers may provide the first step for identifying preclinical treatment recipients in general public. Moreover, the detection of preclinical decline via cognitive markers can increase awareness of AD risk and the motivation for making protective lifestyle changes. The behavioral approach might be expedient for prevention in light of the compelling evidence of lifestyle amelioration of AD risk. In an integrative view, incorporating cognitive markers to primary care may facilitate a synergetic development in preventive interventions that carries epidemiological significance. This paper addresses the theoretical, methodological, and pragmatic aspects of this prospect.


  • Stigma, Social Anxiety, and Illness Severity in Bipolar Disorder: Implications for Treatment

    by Boaz Levy, Elena Tsoy, Madeline Brodt, Karen Petrosyan, Mary Malloy

    Background: Studies indicate that comorbid anxiety disorders predict a more severe course of illness in bipolar disorder (BD). The relatively high prevalence of social anxiety in BD points to the potential role that socio-cultural factors, such as stigma, play in exacerbating the progression of this disorder. Stigma creates social anxiety in affected individuals because it essentially forces them into a vulnerable social status that is marked by public disgrace. Although the etiology of debilitating social anxiety in BD may involve multiple factors, stigma deserves particular clinical attention because research in this area indicates that it is common and its internalization is associated with poor outcome. Methods: We conducted a literature review using search terms related to stigma, social anxiety, bipolar disorder, illness severity, and outcomes. The electronic databases searched included PsychINFO, PubMed, JSTOR, and EBSCO host Academic Search Complete with limits set to include articles published in English. Results: The literature indicates that internalized stigma often triggers the core psychological experiences of social anxiety and is highly correlated with clinical and functional outcome in BD. On a psychological level, internalized stigma and social anxiety can create distress that triggers symptoms of BD. From a biological perspective, stigma constitutes a chronic psychosocial stressor that may interact with the pathophysiology of BD in inflammatory ways. Conclusions: The connection between stigma and social anxiety, and their combined effects on people with BD, carries important implications for psychiatric care. To obtain an accurate clinical formulation, initial evaluations may seek to examine stigma-related experiences and determine their relationship to anxiety symptoms and psychosocial functioning. In addition, direct interventions for reducing the ill effects of stigma in BD deserve clinical attention, because they may carry the potential to enhance outcomes.


  • Autonomic nervous system arousal and cognitive functioning in bipolar disorder

    by Boaz Levy

    Levy B. Autonomic nervous system arousal and cognitive functioning in bipolar disorder. Bipolar Disord 2012: 00: 000–000. © 2012 John Wiley & Sons A/S.Published by Blackwell Publishing Ltd.Objective: Previous theories about the etiology of cognitive dysfunction in bipolar disorder (BD) emphasized trait factors such as neurological impairment. State factors, other than mood symptoms, that may exacerbate functional deficits have not yet been considered. The purpose of this study was to examine autonomic nervous system (ANS) arousal following cognitive challenge. The study compared patients with BD and healthy controls (HC) in physiological measures and neuropsychological test scores.Methods: Thirty euthymic patients with BD and 22 HC completed the study. Participants completed mood [Beck Depression Inventory‐II (BDI‐II) and Young Mania Rating Scale (YMRS)], anxiety (State–Trait Anxiety Inventory), and substance abuse (Drug Abuse Screening Test–20 item and Alcohol Use Disorders Identification Test) measures. They were connected to an electrogram, a sensitive thermometer for measuring finger temperature, and electrodes that measure galvanic skin response. After a five‐min baseline measurement in a restful state, participants completed a computerized neuropsychological battery (CNS Vital Signs).Results: The group with BD reported significantly more mood symptoms (BDI‐II,t = 3.71, p < 0.001; YMRS,t = 6.73, p < 0.001) and scored higher on a measure of trait‐anxiety (State–Trait Anxiety Inventory,t = 2.91, p < 0.001) than HC. A multivariate analysis of variance revealed higher arousal on all physiological measures in the BD group relative to HC at baseline [F(3,48) = 13.1, p < 0.001] and during cognitive testing [F(3,48) = 11.3, p < 0.001]. The increase in physiological arousal from a restful state to the time of testing was higher for the BD group [F(3,37) = 8.06, p < 0.001]. With respect to cognitive data, HC scored higher than patients with BD across the measures of memory (F = 8.5, p < 0.001), sustained (F = 9.5, p < 0.001) and complex (F = 2.7, p < 0.04) attention, processing speed (F = 10.0, p < 0.001), reaction time (F = 7.8, p < 0.001), cognitive flexibility (F = 19.7, p < 0.001), working memory (F = 10.8, p < 0.001), and social acuity (F = 5.7, p < 0.01), with partial eta‐squared from 0.18 to 0.62. Correlational analysis revealed significant associations between various cognitive test scores and changes in physiological arousal from baseline to testing (−0.59 ≤ r ≤ 0.22).Conclusions: Relative to HC, patients with BD experience larger changes in ANS arousal between a restful baseline and cognitive testing, and achieve lower cognitive test scores. Further research is needed to determine whether acute physiological symptoms of anxiety directly compromise cognitive functioning in BD.


  • Recovery of Cognitive Functioning in Patients with Co-Occurring Bipolar Disorder and Alcohol Dependence during Early Remission from An Acute Mood Episode

    by Boaz Levy, Emily Manove, Roger D. Weiss

    Objective: This study aimed to examine cognitive recovery in patients with co-occurring bipolar disorder (BD) and alcohol dependence (AD) during remission from an acute mood disturbance. Method: Fifty-five adult inpatients with bipolar I disorder (BD I) completed a neuropsychological battery, mood measures, and substance abuse measures upon discharge from the hospital and at a 3-month follow-up. Analyses provided group comparisons on these measures between patients who presented with co-occurring AD (n = 21) in the year prior to hospital admission and patients without a substance use disorder (SUD; n = 34). Results: Multivariate analyses of variance detected group differences on measures of visual memory, verbal memory, and executive functioning, using previous number of psychiatric admissions and age of onset of BD as covariates. These differences occurred both at discharge and follow-up. Between discharge and follow-up, the group without SUD exhibited more substantial gains than the group of dually diagnosed patients on free recall of verbal and visual materials and on a measure of cognitive flexibility. Conclusions: Patients with co-occurring BD and AD may suffer from more severe cognitive dysfunction and less favorable recovery of cognitive deficits than patients without SUD over the course of remission from a mood episode.


  • Open Access

    Functional Outcome in Bipolar Disorder: The Big Picture

    by Boaz Levy, Emily Manove

    Previous research on functional outcome in bipolar disorder (BD) has uncovered various factors that exacerbate psychosocial disability over the course of illness, including genetics, illness severity, stress, anxiety, and cognitive impairment. This paper presents an integrated view of these findings that accounts for the precipitous decline in psychosocial functioning after illness onset. The proposed model highlights a number of reciprocal pathways among previously studied factors that trap people in a powerful cycle of ailing forces. The paper discusses implications to patient care as well as the larger social changes required for shifting the functional trajectory of people with BD from psychosocial decline to growth.